NasdaqGS - Nasdaq Real Time Price USD

Amgen Inc. (AMGN)

262.75

-1.32

(-0.50%)

At close: April 18 at 4:00 PM EDT

263.76

+1.01

(+0.38%)

Pre-Market: 7:25 AM EDT

Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.

Zacks yesterday

AMGN
-0.50%
Can This High-Yield Dividend Stock Keep Beating the S&P 500?

Amgen's shares have come under pressure this year, making it a compelling bargain buy.

Motley Fool 2 days ago

AMGN
-0.50%
^GSPC
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

Not every business in operation today is built to thrive -- or even last -- indefinitely. These are.

Motley Fool 2 days ago

DAL

AMGN
-0.50%
^GSPC
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20, from 9:15-11:15 a.m. PDT.

PR Newswire 2 days ago

AMGN
-0.50%
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 3 days ago

AMGN
-0.50%
Amgen (AMGN) Laps the Stock Market: Here's Why

In the most recent trading session, Amgen (AMGN) closed at $270, indicating a +1.33% shift from the previous trading day.

Zacks 7 days ago

AMGN
-0.50%
Is Amgen Stock a Buy?

Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.

Motley Fool 7 days ago

AMGN
-0.50%
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at Tema

MarketWatch 8 days ago

NVO

VRTX
+0.10%
LLY
-0.64%
11 Best Biotech ETFs To Buy

In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artificial intelligence. According to The Journal of mHealth, the focus […]

Insider Monkey 9 days ago

AMGN
-0.50%
NTRA

NBIX
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

It’s been a volatile start to the second quarter for many sectors. However, investors continue to seek out undervalued biotech stocks for robust returns over the long term. Plenty of options exist in various niches within the biotech sector. That said, investor focus remains on key sectors, including weight-loss drugs, Parkinson’s treatments and drugs aimed at Alzheimer’s. It’s worth pointing out that biotech stocks are among some of the higher-risk options in the market. These companies’ massiv

InvestorPlace 10 days ago

LLY
-0.64%
AMGN
-0.50%
VRTX
+0.10%
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024

Looking ahead, the future of the U.S. economy appears promising despite ongoing challenges. President Biden’s efforts to steer the economy through inflation concerns are showing strong results. Recent data indicates a healthy economic position, with significant GDP growth outpacing other developed nations. Despite fluctuations in inflation and interest rates, the U.S. labor market remains resilient, adding jobs at a rapid pace. The country’s economic resilience, bolstered by substantial fiscal s

InvestorPlace 11 days ago

AMGN
-0.50%
HD

MRK
-0.11%
Fund manager of $100 million long/short mutual fund explains pair trade strategy

Joseph Artuso of Easterly Investment Partners knows how to hedge a portfolio.

TheStreet 12 days ago

AMGN
-0.50%
10 Best Weight Loss Drug Stocks to Buy Now

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it’s one of the biggest trends on the stock market right now, then you can take a look at the […]

Insider Monkey 12 days ago

LLY
-0.64%
NVO

VKTX
13 Best Cheap Dividend Stocks To Buy Right Now

In this article, we discuss 13 best cheap dividend stocks to buy right now. You can skip our detailed analysis of value dividend stocks and overall performance of dividend stocks, and go directly to read 5 Best Cheap Dividend Stocks To Buy Right Now. Growth stocks took the lead in 2023, driven by the ‘Magnificent […]

Insider Monkey 12 days ago

CVX

LMT

AMGN
-0.50%
2 Biotech Stocks to Buy Hand Over Fist in April

These drugmakers have made important moves over the past year.

Motley Fool 12 days ago

AMGN
-0.50%
SRPT
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note

Amgen (AMGN) concluded the recent trading session at $269.95, signifying a +0.69% move from its prior day's close.

Zacks 13 days ago

AMGN
-0.50%
^GSPC
3 Stocks to Consider Adding to Your Retirement Portfolio in April

Use the recent short-term weakness from these powerhouse companies' stocks to your advantage.

Motley Fool 14 days ago

AMGN
-0.50%
SNOW
Merck puts KRAS cancer drug competitor to the test

A Phase 3 study will compare Merck’s experimental KRAS inhibitor together with its immunotherapy Keytruda against Keytruda alone in lung cancer.

BioPharma Dive 14 days ago

MRK
-0.11%
AMGN
-0.50%
CELG-RT
Here's Why Amgen (AMGN) Stock is Outperforming the Industry

Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to make up for lower revenues from oncology biosimilars and Enbrel

Zacks 15 days ago

AMGN
-0.50%
ADMA

VNDA
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Amgen (AMGN) closed the most recent trading day at $283.04, moving -0.45% from the previous trading session.

Zacks 17 days ago

AMGN
-0.50%
^GSPC

Performance Overview

Return	AMGN	S&P 500
YTD	-8.06%	+5.06%
1-Year	+9.48%	+20.71%
3-Year	+13.11%	+19.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Amgen Inc. (AMGN)

Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Can This High-Yield Dividend Stock Keep Beating the S&P 500?

Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen (AMGN) Laps the Stock Market: Here's Why

Is Amgen Stock a Buy?

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

11 Best Biotech ETFs To Buy

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024

Fund manager of $100 million long/short mutual fund explains pair trade strategy

10 Best Weight Loss Drug Stocks to Buy Now

13 Best Cheap Dividend Stocks To Buy Right Now

2 Biotech Stocks to Buy Hand Over Fist in April

Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note

3 Stocks to Consider Adding to Your Retirement Portfolio in April

Merck puts KRAS cancer drug competitor to the test

Here's Why Amgen (AMGN) Stock is Outperforming the Industry

Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Performance Overview